Delivery Order SPE2DR25D3012-SPE2DR26F4C2N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on August 28, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order is unclassified as a set-aside contract and represents a competitive award to the pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $6,497.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Benlysta 200 mg/mL auto-injectors. The contract, which represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by December 10, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on August 19, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors in the...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, placing performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed-price delivery order with an ultimate completion date of December 30, 2025, and was awarded competitively with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector medication. The award was made on November 4, 2025, with an ultimate completion date of November 26, 2025, under a firm fixed-price delivery order contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The contract is set to be completed by October 14, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 2, 2025, with an ultimate completion date of December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic medication...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with DLA to supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 17, 2025. This is a firm fixed-price delivery order with a completion date of December 9, 2025, with no set-aside designation applied. The award represents a competitive procurement under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's established capability as a major pharmaceutical distributor...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C2NDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 24, 2025, with an ultimate completion date of December 16, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters and distribution facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. The Benlysta auto-injector—a biologic treatment for systemic lupus erythematosus—represents the type of specialized pharmaceutical commodity delivered under this strategic contract, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/23/25 |